EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduction in Hippocampal Amyloid-β Peptide (Aβ) Content during Glycine-Proline-Glutamate (Gly-Pro-Glu) Co-Administration Is Associated with Changes in Inflammation and Insulin-like Growth Factor (IGF)-I Signaling

Laura M Frago iD, Emma Burgos-Ramos iD, María Rodríguez-Pérez iD, Sandra Canelles, Eduardo Arilla-Ferreiro, Jesús Argente iD, Manuela G López iD, Vicente Barrios iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25115716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Laura M Frago und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Research Institute "La Princesa", E-28009 Madrid, Sp…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Hippocampus, Insulin-Like Growth Factor I, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regional Government of Castile-La Mancha, Ministerio de Ciencia, Innovación y Universidades, Comunidad de Madrid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is characterized by the deposition in the brain of senile plaques composed of amyloid-β peptides (Aβs) that increase inflammation. An endogenous peptide derived from the insulin-like growth factor (IGF)-I, glycine-proline-glutamate (GPE), has IGF-I-sensitizing and neuroprotective actions. Here, we examined the effects of GPE on Aβ levels and hippocampal inflammation generated by the intracerebroventricular infusion of Aβ25-35 for 2 weeks (300 pmol/day) in ovariectomized rats and the signaling-related pathways and levels of Aβ-degrading enzymes associated with these GPE-related effects. GPE prevented the Aβ-induced increase in the phosphorylation of p38 mitogen-activated protein kinase and the reduction in activation of signal transducer and activator of transcription 3, insulin receptor substrate-1, and Akt, as well as on interleukin (IL)-2 and IL-13 levels in the hippocampus. The functionality of somatostatin, measured as the percentage of inhibition of adenylate cyclase activity and the levels of insulin-degrading enzyme, was also preserved by GPE co-treatment. These findings indicate that GPE co-administration may protect from Aβ insult by changing hippocampal cytokine content and somatostatin functionality through regulation of leptin- and IGF-I-signaling pathways that could influence the reduction in Aβ levels through modulation of levels and/or activity of Aβ proteases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesHippocampusInsulin-Like Growth Factor ISignal TransductionOligopeptidesAnimalsRatsFemaleInflammationPeptide FragmentsRats, WistarAlzheimer Diseasep38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktInsulin-Like Peptides

Stichwörter der Autor:innen

Alzheimer’s diseaseGly-Pro-GluIGF-I signalingcytokinesinflammation

Substanzen

Amyloid beta-PeptidesInsulin-Like Growth Factor Iglycyl-prolyl-glutamic acidOligopeptidesPeptide Fragmentsp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktInsulin-Like Peptides

Autor:innen und Institutionen

  • Departments of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Research Institute "La Princesa", E-28009 Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutriciόn, Instituto de Salud Carlos III, E-28009 Madrid, Spain.
  • Department of Pediatrics, Universidad Autónoma de Madrid, E-28049 Madrid, Spain.
  • Biochemistry Area, Faculty of Environmental Sciences and Biochemistry, Universidad de Castilla-La Mancha, E-45071 Toledo, Spain.
  • Department of Biological Systems, Faculty of Medicine, Universidad de Alcalá, E-28871 Alcala de Henares, Spain.
  • IMDEA, Food Institute, CEIUAM+CSI, Cantoblanco, E-28049 Madrid, Spain.

ORCID-Profile: Laura M Frago, Emma Burgos-Ramos, María Rodríguez-Pérez, Jesús Argente, Manuela G López, Vicente Barrios

Förderung

  • Regional Government of Castile-La Mancha
  • Ministerio de Ciencia, Innovación y Universidades
  • Comunidad de Madrid
  • Centro de Investigación Biomédica en Red
  • Junta de Comunidades de Castilla-La Mancha (JCCM)
  • Ministerio de Ciencia e Innovación

Zitieren

APA

Frago, L. M., Burgos-Ramos, E., Rodríguez-Pérez, M., Canelles, S., Arilla-Ferreiro, E., Argente, J., López, M. G., & Barrios, V. (2024). Reduction in Hippocampal Amyloid-β Peptide (Aβ) Content during Glycine-Proline-Glutamate (Gly-Pro-Glu) Co-Administration Is Associated with Changes in Inflammation and Insulin-like Growth Factor (IGF)-I Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115716

Vancouver

Frago LM, Burgos-Ramos E, Rodríguez-Pérez M, Canelles S, Arilla-Ferreiro E, Argente J, et al. Reduction in Hippocampal Amyloid-β Peptide (Aβ) Content during Glycine-Proline-Glutamate (Gly-Pro-Glu) Co-Administration Is Associated with Changes in Inflammation and Insulin-like Growth Factor (IGF)-I Signaling. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115716

BibTeX
@article{Frago2024,
  author = {Frago, Laura M and Burgos-Ramos, Emma and Rodríguez-Pérez, María and Canelles, Sandra and Arilla-Ferreiro, Eduardo and Argente, Jesús and López, Manuela G and Barrios, Vicente},
  title = {Reduction in Hippocampal Amyloid-β Peptide (Aβ) Content during Glycine-Proline-Glutamate (Gly-Pro-Glu) Co-Administration Is Associated with Changes in Inflammation and Insulin-like Growth Factor (IGF)-I Signaling},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25115716}
}
Kostenlos starten →